Updated consensus statement on biological agents, specifically tumour necrosis factor   (TNF ) blocking agents and interleukin-1 receptor antagonist (IL-1ra), for the treatment of rheumatic diseases, 2005

Updated consensus statement on biological agents, specifically tumour necrosis factor (TNF ) blocking agents and interleukin-1 receptor antagonist (IL-1ra), for the treatment of rheumatic diseases, 2004

Annals of the Rheumatic Diseases ◽

10.1136/ard.2004.029272 ◽

2004 ◽

Vol 63 (suppl_2) ◽

pp. ii2-ii12 ◽

Cited By ~ 28

Author(s):

D E Furst

Keyword(s):

Receptor Antagonist ◽

Tumour Necrosis Factor ◽

Rheumatic Diseases ◽

Tumour Necrosis ◽

Consensus Statement ◽

Interleukin 1 ◽

Biological Agents ◽

Blocking Agents ◽

Tumour necrosis factor soluble receptors I and II and interleukin-1 receptor antagonist in acute pyelonephritis in relation to bacterial virulence-associated traits and renal function

Nephrology Dialysis Transplantation ◽

10.1093/ndt/11.11.2209 ◽

1996 ◽

Keyword(s):

Renal Function ◽

Receptor Antagonist ◽

Tumour Necrosis Factor ◽

Acute Pyelonephritis ◽

Tumour Necrosis ◽

Interleukin 1 ◽

Bacterial Virulence ◽

Soluble Receptors ◽

Circulating interleukin-6, tumour necrosis factor soluble receptor-II, interleukin-1 receptor antagonist, and serum procalcitonin in patients with heat stroke: Prognostic implications

Intensive Care Medicine ◽

10.1007/bf01921185 ◽

1996 ◽

Vol 22 (S1) ◽

pp. S11-S11

Author(s):

A Alzeer ◽

A Al-Arifi ◽

Z Ansari ◽

I Hashim ◽

E Nylen ◽

...

Keyword(s):

Receptor Antagonist ◽

Tumour Necrosis Factor ◽

Interleukin 6 ◽

Tumour Necrosis ◽

Interleukin 1 ◽

Heat Stroke ◽

Soluble Receptor ◽

Prognostic Implications ◽

Safety of tumour necrosis factor and interleukin-1 blocking agents in rheumatic diseases

Autoimmunity Reviews ◽

10.1016/j.autrev.2004.09.001 ◽

2005 ◽

Vol 4 (3) ◽

pp. 162-170 ◽

Cited By ~ 39

Author(s):

C BOTSIOS

Keyword(s):

Tumour Necrosis Factor ◽

Rheumatic Diseases ◽

Tumour Necrosis ◽

Interleukin 1 ◽

Blocking Agents ◽

Human mesangial cells synthesize interleukin 1α but not interleukin 1β, interleukin 1 receptor antagonist, or tumour necrosis factor

Nephrology Dialysis Transplantation ◽

10.1093/ndt/7.10.997 ◽

1992 ◽

Keyword(s):

Receptor Antagonist ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Mesangial Cells ◽

Interleukin 1 ◽

Interleukin 1Β ◽

Human Mesangial Cells ◽

Interleukin 1Α ◽

Induction of circulating soluble tumour necrosis factor receptor and interleukin 1 receptor antagonist following interleukin 1α infusion in humans

Cytokine ◽

10.1016/1043-4666(94)90044-2 ◽

1994 ◽

Vol 6 (2) ◽

pp. 215-219 ◽

Cited By ~ 26

Author(s):

Herbert Tilg ◽

Elizabeth Trehu ◽

Leland Shapiro ◽

Dietrich Pape ◽

Michael B. Atkins ◽

...

Keyword(s):

Receptor Antagonist ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Interleukin 1 ◽

Tumour Necrosis Factor Receptor ◽

Interleukin 1Α ◽

Tumour necrosis factor soluble receptors I and II and interleukin-1 receptor antagonist in acute pyelonephritis in relation to bacterial virulence-associated traits and renal function

Nephrology Dialysis Transplantation ◽

10.1093/oxfordjournals.ndt.a027138 ◽

1996 ◽

Vol 11 (11) ◽

pp. 2209-2214 ◽

Cited By ~ 8

Author(s):

S. H. Jacobson ◽

Y. Lu ◽

A. Brauner

Keyword(s):

Renal Function ◽

Receptor Antagonist ◽

Tumour Necrosis Factor ◽

Acute Pyelonephritis ◽

Tumour Necrosis ◽

Interleukin 1 ◽

Bacterial Virulence ◽

Soluble Receptors ◽

Endocrinology: Ovarian hyperstimulation syndrome: pre-ovulatory serum concentrations of interleukin-6, interleukin-1 receptor antagonist and tumour necrosis factor- cannot predict its occurrence

Human Reproduction ◽

10.1093/oxfordjournals.humrep.a019403 ◽

1996 ◽

Vol 11 (7) ◽

pp. 1377-1380 ◽

Cited By ~ 17

Author(s):

J. R. L. de Mola ◽

G. P. Baumgardner ◽

J. M. Goldfarb ◽

M. A. Friedlander

Keyword(s):

Receptor Antagonist ◽

Tumour Necrosis Factor ◽

Interleukin 6 ◽

Tumour Necrosis ◽

Ovarian Hyperstimulation Syndrome ◽

Interleukin 1 ◽

Ovarian Hyperstimulation ◽

Serum Concentrations ◽

Immunoglobulin D enhances the release of tumour necrosis factor‐α, and interleukin‐1β as well as interleukin‐1 receptor antagonist from human mononuclear cells

Immunology ◽

10.1046/j.1365-2567.1996.d01-672.x ◽

1996 ◽

Vol 88 (3) ◽

pp. 355-362 ◽

Cited By ~ 62

Author(s):

J. P. H. DRENTH ◽

J. GÖERTZ ◽

M. R. DAHA ◽

J. W. M. VAN DER MEER

Keyword(s):

Receptor Antagonist ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Mononuclear Cells ◽

Interleukin 1 ◽

Tumour Necrosis Factor Α ◽

Human Mononuclear Cells ◽

Immunoglobulin D ◽

Factor Α ◽

Increased circulating cytokine receptors and ex vivo interleukin-1 receptor antagonist and interleukin-1β production but decreased tumour necrosis factor-α production after a 5-km run

European Journal of Clinical Investigation ◽

10.1046/j.1365-2362.1998.00366.x ◽

1998 ◽

Vol 28 (10) ◽

pp. 866-872 ◽

Cited By ~ 46

Author(s):

Drenth ◽

Krebbers ◽

Bijzet ◽

Van Der Meer

Keyword(s):

Receptor Antagonist ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Ex Vivo ◽

Interleukin 1 ◽

Interleukin 1Β ◽

Cytokine Receptors ◽

Tumour Necrosis Factor Α ◽

Factor Α ◽